Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.46 |
| ▸ | KDM4A | O75164 | 1/20 | 0.46 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.46 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | PAM | P19021 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18058738 | 1.00 | CYP1A2 (0.53) | CYP1A2KMT2AMAPTALDH1A1CYP3A4 | |
| SCHEMBL27952099 | 1.00 | CYP1A2 (0.53) | CYP1A2KMT2AMAPTALDH1A1CYP3A4 | |
| SCHEMBL17000166 | 1.00 | CYP1A2 (0.53) | CYP1A2KMT2AMAPTALDH1A1CYP3A4 | |
| SCHEMBL19861152 | 1.00 | CYP1A2 (0.53) | CYP1A2KMT2AMAPTALDH1A1CYP3A4 | |
| SCHEMBL29074095 | 1.00 | CYP1A2 (0.53) | CYP1A2KMT2AMAPTALDH1A1CYP3A4 | |
| SCHEMBL27896610 | 1.00 | CYP1A2 (0.53) | CYP1A2KMT2AMAPTALDH1A1CYP3A4 | |
| SCHEMBL2209491 | 1.00 | CYP1A2 (0.53) | CYP1A2KMT2AMAPTALDH1A1CYP3A4 | |
| SCHEMBL17000165 | 1.00 | CYP1A2 (0.53) | CYP1A2KMT2AMAPTALDH1A1CYP3A4 | |
| SCHEMBL15130566 | 1.00 | CYP1A2 (0.53) | CYP1A2KMT2AMAPTALDH1A1CYP3A4 | |
| SCHEMBL952321 | 0.98 | CYP1A2 (0.55) | CYP1A2KMT2AMAPTALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1993580-A1 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | Moleac Pte Ltd. (SG) | 2008-11-26 | — | — | EP | claimed |
| WO-2007106049-A1 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | MOLEAC PTE LTD (SG) | 2007-09-20 | — | — | WO | claimed |
| CN-115025017-A | Ligusticum wallichii and cimicifugae foetidae mixed enzymatic hydrolysate and application thereof | 齐鲁工业大学 | 2022-09-09 | — | — | CN | disclosed |
| CN-115025016-A | Ligusticum wallichii enzymatic hydrolysate and application thereof | 齐鲁工业大学 | 2022-09-09 | — | — | CN | disclosed |
| CN-113648393-A | Fermented traditional Chinese medicine composition for preventing salpingitis of laying hens and improving laying performance of laying hens | 聊城大学 | 2021-11-16 | — | — | CN | disclosed |
| CN-104597153-B | Assay method of ligusticum wallichii fingerprint | 上海现代中医药股份有限公司 | 2017-02-01 | — | — | CN | disclosed |
| CN-104569268-B | A kind of assay method of Rhizoma Chuanxiong volatile oil clathrate finger printing | 上海现代中医药股份有限公司 | 2016-11-02 | — | — | CN | disclosed |
| CN-104597153-A | Assay method of ligusticum wallichii fingerprint | SHANGHAI SUNDISE TRADITIONAL CHINESE MEDICINE CO LTD | 2015-05-06 | — | — | CN | disclosed |
| CN-104569268-A | Testing method of ligusticum chuanxiong hort volatile oil inclusion compound fingerprint spectrum | SHANGHAI SUNDISE TRADITIONAL CHINESE MEDICINE CO LTD | 2015-04-29 | — | — | CN | disclosed |
| CN-103013630-A | Liquid lubricant | NANTONG HUADONG HYDRAULIC & LUBRICATE EQUIPMENT CO LTD | 2013-04-03 | — | — | CN | disclosed |
| EP-2508191-A1 | Combination therapy for treatment of patients with neurological disorders and cerebral infarction | Moleac Pte Ltd. (SG) | 2012-10-10 | — | — | EP | disclosed |
| US-20090162459-A1 | Combination Therapy for Treatment of Patients with Neurological Disorders and Cerebral Infarction | MOLEAC PTE. LTD (SG) | 2009-06-25 | — | — | US | disclosed |
| EP-1993580-A1 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | Moleac Pte Ltd. (SG) | 2008-11-26 | — | — | EP | disclosed |
| WO-2007106049-A1 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | MOLEAC PTE LTD (SG) | 2007-09-20 | — | — | WO | disclosed |